MC▼
PhRMA names former House Majority Leader Eric Cantor as next CEO
The Pharmaceutical Research and Manufacturers of America has selected former Republican House Majority Leader Eric Cantor as its next CEO and president, effective Nov. 9. Cantor succeeds Steven Ubl, who has held the CEO and president roles since 2015. Merck CEO and PhRMA Board Chair Rob Davis said in a statement that Cantor's unique combination of global business acumen coupled with policy and political experience at the highest levels of government make him an ideal person to lead PhRMA during this critical next chapter. Cantor served in the House from 2000 to 2014 and was House majority leader from 2011 to 2014. Since leaving Congress, he has been vice chairman and managing director at investment bank Moelis & Company, advising companies on business strategy, mergers and acquisitions, and public policy.
MC · Capital · Negative Cantor is leaving his vice chairman/managing director role at Moelis to become PhRMA CEO, a loss of a senior executive.